| 000 | 01301 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250512013314.0 | ||
| 264 | 0 | _c19900103 | |
| 008 | 199001s 0 0 eng d | ||
| 022 | _a0006-4971 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLieschke, G J | |
| 245 | 0 | 0 |
_aCharacterization of the clinical effects after the first dose of bacterially synthesized recombinant human granulocyte-macrophage colony-stimulating factor. _h[electronic resource] |
| 260 |
_bBlood _cDec 1989 |
||
| 300 |
_a2634-43 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aColony-Stimulating Factors _xadministration & dosage |
| 650 | 0 | 4 |
_aComplement System Proteins _xmetabolism |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aDrug Evaluation |
| 650 | 0 | 4 | _aGranulocyte-Macrophage Colony-Stimulating Factor |
| 650 | 0 | 4 |
_aGrowth Substances _xadministration & dosage |
| 650 | 0 | 4 |
_aHistamine _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukopenia _xchemically induced |
| 650 | 0 | 4 |
_aOxygen _xadministration & dosage |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 650 | 0 | 4 | _aRespiratory Function Tests |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aCebon, J | |
| 700 | 1 | _aMorstyn, G | |
| 773 | 0 |
_tBlood _gvol. 74 _gno. 8 _gp. 2634-43 |
|
| 999 |
_c2690178 _d2690178 |
||